Of particular significance, the combination of NSC303244 (CpPyK inhibitor) and NSC158011 (CpLDH inhibitor) was successful in preventing relapse of infection in IFN-γ knockout mice, a suitable and widely used immunodeficient model of cryptosporidiosis (22), even after discontinuation of treatment. This evidence concerns the gene IFNG and cryptosporidiosis.